This category needs an editor. We encourage you to help if you are qualified.
Volunteer, or read more about what this involves.
Related categories
Siblings:
24 found
Search inside:
(import / add options)   Sort by:
  1. Hans‐Gert Bernstein & Thomas M. Malone (2009). Comment on “The Emerging Roles of Cystatins in Alzheimer's Disease” DOI 10.1002/Bies.200900012. Bioessays 31 (9):1004-1005.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  2. Sandra E. Black, Attentional Networks in Normal Aging and Alzheimer's Disease.
    By combining a flanker task and a cuing task into a single paradigm, the authors assessed the effects of orienting and alerting on conflict resolution and explored how normal aging and Alzheimer’s disease (AD) modulate these attentional functions. Orienting failed to enhance conflict resolution; alerting was most beneficial for trials without conflict, as if acting on response criterion rather than on information processing. Alerting cues were most effective in the older groups— healthy aging and AD. Conflict resolution was impaired only (...)
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  3. Alan Blum (2012). The Enigma of the Brain and its Place as Cause, Character and Pretext in the Imaginary of Dementia. History of the Human Sciences 25 (4):108-124.
    An analysis of the collective engagement with the disease known as Alzheimer’s and the dementia reputed of it reveals recourse to a socially standardized formula that attributes causal agency to the brain in the absence of clinching knowledge. I propose that what Baudrillard calls the model of molecular idealism stipulates such a neurological view of determinism in order to provide caregivers with reassurance in the face of the perplexing character of dementia and the depressing reactions to mortality that it brings (...)
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  4. Fiona Crawford & Alison Goate (1992). Alzheimer's Disease Untangled. Bioessays 14 (11):727-734.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  5. R. Anthony Crowther (1995). Steps Towards a Mouse Model of Alzheimer's Disease. Bioessays 17 (7):593-595.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  6. Georg Fuellen, Melanie Börries, Hauke Busch, Aubrey de Grey, Udo Hahn, Thomas Hiller, Andreas Hoeflich, Ludger Jansen, Georges E. Janssens, Christoph Kaleta, Anne C. Meinema, Sascha Schäuble, Paul N. Schofield, Barry Smith & Daniel Wuttke (2013). In-Silico-Approaches and the Role of Ontologies in Aging Research. Rejuvenation Research 16 (6):540-546.
    The 2013 Rostock Symposium on Systems Biology and Bioinformatics in Aging Research was again dedicated to dissecting the aging process using in silico means. A particular focus was on ontologies, as these are a key technology to systematically integrate heterogeneous information about the aging process. Related topics were databases and data integration. Other talks tackled modeling issues and applications, the latter including talks focussed on marker development and cellular stress as well as on diseases, in particular on diseases of kidney (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  7. Atwood D. Gaines (2006). Alzheimer's Disease, Aging, Chance, and Race. Philosophy, Psychiatry, and Psychology 13 (1):83-85.
  8. Atwood D. Gaines & Peter J. Whitehouse (2006). Building a Mystery: Alzheimer's Disease, Mild Cognitive Impairment, and Beyond. Philosophy, Psychiatry, and Psychology 13 (1):61-74.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  9. S. Janciauskiene & H. T. Wright (1998). Inflammation, Antichymotrypsin, and Lipid Metabolism: Autogenic Etiology of Alzheimer's Disease. Bioessays 20 (12):1039-1046.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  10. Mark Jensen, Alexander P. Cox, Naveed Chaudhry, Marcus Ng, Donat Sule Ray, William Duncan, Patrick, Bianca Weinstock-Guttman, Barry Smith, Alan Ruttenberg, Kinga Szigeti & Alexander D. Diehl (2013). The Neurological Disease Ontology. Journal of Biomedical Semantics 4 (42).
    We are developing the Neurological Disease Ontology (ND) to provide a framework to enable representation of aspects of neurological diseases that are relevant to their treatment and study. ND is a representational tool that addresses the need for unambiguous annotation, storage, and retrieval of data associated with the treatment and study of neurological diseases. ND is being developed in compliance with the Open Biomedical Ontology Foundry principles and builds upon the paradigm established by the Ontology for General Medical Science (OGMS) (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  11. Natalia V. Koudinova (2003). Alzheimer's Amyloid Beta Oligomers and Lipoprotein apoA?: Mistaken Identity is Possible. Bioessays 25 (10):1024-1024.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  12. Kun Ping Lu, Yih-Cherng Liou & Inez Vincent (2003). Proline-Directed Phosphorylation and Isomerization in Mitotic Regulation and in Alzheimer's Disease. Bioessays 25 (2):174-181.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  13. Mark P. Mattson (2012). An ECSIT‐Centric View of Alzheimer's Disease (Comment on DOI 10.1002/Bies. 201100193). Bioessays 34 (7):526-527.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  14. Niklas Mattsson, David Brax & Henrik Zetterberg (2010). To Know or Not to Know - Ethical Issues Related to Early Diagnosis of Alzheimer's Disease. International Journal of Alzheimer's Disease.
    In Alzheimer's disease (AD), pathological processes start in the brain long before clinical dementia. Biomarkers reflecting brain alterations may therefore indicate disease at an early stage, enabling early diagnosis. This raises several ethical questions and the potential benefits of early diagnosis must be weighted against possible disadvantages. Currently, there are few strong arguments favouring early diagnosis, due to the lack of disease modifying therapy. Also, available diagnostic methods risk erroneous classifications, with potentially grave consequences. However, a possible benefit of early (...)
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  15. M. Hasan Mohajeri (2007). The Underestimated Potential of the Immune System in Prevention of Alzheimer's Disease Pathology. Bioessays 29 (9):927-932.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  16. Thierry Nouspikel & Philip C. Hanawalt (2003). When Parsimony Backfires: Neglecting DNA Repair May Doom Neurons in Alzheimer's Disease. Bioessays 25 (2):168-173.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  17. Donald L. Price, Edward H. Koo & Axel Unterbeck (1989). Cellular and Molecular Biology of Alzheimer's Disease. Bioessays 10 (2-3):69-74.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  18. Stephen R. Robinson, Glenda M. Bishop & Gerald M.�nch (2003). Alzheimer Vaccine: Amyloid-? On Trial. Bioessays 25 (3):283-288.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  19. Stephen R. Robinson, Glenda M. Bishop & Gerald M.�nch (2003). Alzheimer Vaccine: An Update. Bioessays 25 (10):1025-1025.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  20. Stephen R. Robinson, Glenda M. Bishop & Gerald Münch (2003). Alzheimer Vaccine: Amyloid‐Β on Trial. Bioessays 25 (3):283-288.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  21. Stephen R. Robinson, Glenda M. Bishop & Gerald Münch (2003). Alzheimer Vaccine: An Update. Bioessays 25 (10):1025-1025.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  22. Montserrat Soler‐López, Nahuai Badiola, Andreas Zanzoni & Patrick Aloy (2012). Towards Alzheimer's Root Cause: ECSIT as an Integrating Hub Between Oxidative Stress, Inflammation and Mitochondrial Dysfunction. Bioessays 34 (7):532-541.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  23. H. T. Wright (2000). Alzheimer's Disease and Related Disorders. Etiology, Pathogenesis, and Therapeutics. Bioessays 22 (7):682-683.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  24. Eva Žerovnik (2009). The Emerging Role of Cystatins in Alzheimer's Disease. Bioessays 31 (6):597-599.
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation